Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | RLY-1971 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RLY-1971 | RLY1971|RLY 1971|RG-6433|RG6433 | SHP2 Inhibitor 14 | RLY-1971 is a Shp2 inhibitor that inhibits MAPK signaling and inhibits cell growth (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04252339 | Phase I | RLY-1971 | RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors | Active, not recruiting | USA | 0 |